Paper4626348
[Restoration by phenylimidothiazole of the immunological response of aged mice].
Renoux G and 1 other. C R Acad Hebd Seances Acad Sci D, 1972. Cited by 28 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. [Restoration by phenylimidothiazole of the immunological response of aged mice]. Papers, record 4626348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4626348
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Antibody Formation | Major topic |
| Antibody-Producing Cells | Major topic |
| Thiazoles | Major topic |
| Animals | |
| Erythrocytes | |
| Female | |
| Hemolytic Plaque Technique | |
| Mice | |
| Sheep | |
| Spleen |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6995097 | The general immunopharmacology of levamisole. | Drugs | 1980 | https://conductscience.org/library/papers/6995097 | PubMed |
| 6716911 | Immunostimulation. Clinical and experimental perspectives. | Klin Wochenschr | 1984 | https://conductscience.org/library/papers/6716911 | PubMed |
| 6203843 | The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. | Infection | 1984 | https://conductscience.org/library/papers/6203843 | PubMed |
| 6190840 | Restoration of immune responses of aging hamsters by treatment with isoprinosine. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6190840 | PubMed |
| 4200541 | Stimulation of anti-Brucella vaccination in mice by tetramisole, a phenyl-imidothiazole salt. | Infect Immun | 1973 | https://conductscience.org/library/papers/4200541 | PubMed |
| 2414227 | The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections. | Infection | 1985 | https://conductscience.org/library/papers/2414227 | PubMed |
| 1233079 | Levamisole treatment of local and metastatic growth of transplanted rat tumours. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1233079 | PubMed |
| 1083786 | In vitro stimulation of murine lymphoid cell cultures by levamisole. | Clin Exp Immunol | 1975 | https://conductscience.org/library/papers/1083786 | PubMed |
| 392478 | Fungal endocarditis: patients at risk and their treatment. | Postgrad Med J | 1979 | https://conductscience.org/library/papers/392478 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4626348
GET https://conductscience.org/api/papers/v1/4626348/authors